Fisher Asset Management
TRAX

Fisher Asset Management’s First Tracks Biotherapeutics TRAX Stock Holding History

Fisher Asset Management’s Portfolio TRAX Stock Details TRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
+51,549
New +$964K ﹤0.01% 694

Other funds holding TRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
FEG
Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Fisher Asset Management's TRAX Position: Q2 2026 in Review

Fisher Asset Management opened a new position in First Tracks Biotherapeutics (TRAX) in Q2 2026: 51,549 shares worth $1.04M. The stake represents ﹤0.01% of the portfolio and ranks #694 among its holdings.

38 funds tracked by Wall St. Rank hold TRAX as of Q2 2026.

  • Fisher Asset Management held 51,549 shares of First Tracks Biotherapeutics worth $1.04M as of Q2 2026.
  • First Tracks Biotherapeutics was a new Fisher Asset Management position in Q2 2026.
  • First Tracks Biotherapeutics made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #694 holding.
  • 38 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.